Related Experiment Video

Updated: Apr 3, 2026

Magnetic Isolation of Microglial Cells from Neonate Mouse for Primary Cell Cultures
07:23

Magnetic Isolation of Microglial Cells from Neonate Mouse for Primary Cell Cultures

Published on: July 25, 2022

3.8K

Modulation of BV-2 microglia functions by novel quercetin pivaloyl ester

Nataša Mrvová1, Martin Škandík1, Marcela Kuniaková2

  • 1Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dubravska cesta 9, 841 04 Bratislava, Slovak Republic.

Neurochemistry International
|September 20, 2015
PubMed

Insights

A new compound, 3'-O-(3-chloropivaloyl) quercetin (CPQ), shows potential as an anti-inflammatory drug for neurodegenerative diseases by modulating microglial functions and reducing inflammatory markers more effectively than quercetin.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Chronic neuroinflammation driven by microglia is implicated in neurodegenerative diseases like Alzheimer's and Parkinson's.
  • Quercetin, a natural flavonoid, downregulates inflammatory genes in microglia.
  • 3 -O-(3-chloropivaloyl) quercetin (CPQ) is a modified quercetin with potentially enhanced bioavailability and antioxidant properties.

Purpose of the Study:

  • To assess the anti-neuroinflammatory capability of the novel compound CPQ in BV-2 microglial cells.
  • To compare the efficacy of CPQ with quercetin in modulating microglial inflammatory responses.

Main Methods:

  • BV-2 microglial cells were stimulated with lipopolysaccharide (LPS) or phorbol 12-myristate 13-acetate (PMA).
  • Treatment groups included CPQ, quercetin, and controls.
  • Assessed production of nitric oxide (NO), tumor necrosis factor-α (TNF-α), inducible NO synthase (iNOS) protein, NFκB activation, superoxide generation, cell proliferation, and phagocytosis.

Main Results:

  • CPQ attenuated NO and TNF-α production more efficiently than quercetin in LPS-stimulated microglia.
  • CPQ demonstrated superior suppression of iNOS protein levels and NFκB activation compared to quercetin.
  • CPQ significantly inhibited BV-2 microglia proliferation without affecting cell viability or phagocytosis.

Conclusions:

  • CPQ exhibits potent anti-neuroinflammatory effects, surpassing quercetin in modulating key inflammatory mediators and pathways.
  • CPQ demonstrates therapeutic potential as a novel anti-inflammatory agent for neurodegenerative diseases.
  • CPQ favorably modulates pro-inflammatory microglial functions, suggesting its utility in treating conditions associated with chronic neuroinflammation.
Keywords:
3′-O-(3-chloropivaloyl)quercetinAnti-neuroinflammatory efficacyBV-2 microgliaQuercetin

More Related Videos

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact11:29

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact

Published on: July 17, 2016

29.0K
Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds07:13

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds

Published on: August 8, 2025

2.0K

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
893
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
39